Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant
Abeer S Aloufi1, Mohammed S Abdulrahman2,3, Amr H Hashem4
1Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Plos One
|July 2, 2026
Summary
This study presents a green synthesis of silver-selenium nanocomposite (Ag-Se NC) with dual anticancer and antibacterial properties. The novel Ag-Se NC effectively inhibits malignant cells and combats vancomycin-resistant Staphylococcus aureus (VRSA) infections, including biofilms.
Area of Science:
- Nanotechnology
- Materials Science
- Biotechnology
Background:
- The rise of multi-drug resistant (MDR) bacteria and cancer necessitates novel therapeutic agents.
- Vancomycin-resistant Staphylococcus aureus (VRSA) is a high-priority antimicrobial resistance (AMR) pathogen.
- Developing multifunctional therapeutic agents is crucial for addressing these global health challenges.
Purpose of the Study:
- To ecofriendly synthesize silver-selenium nanocomposite (Ag-Se NC) using Cucumis melo (C. melo) extract.
- To evaluate the in vitro anticancer efficacy of the synthesized Ag-Se NC against cancer cell lines.
- To assess the inhibitory activity of Ag-Se NC against clinical isolates of VRSA, including biofilm formation.
Main Methods:
- Green synthesis of Ag-Se NC using C. melo peel extract.
- Physicochemical characterization of Ag-Se NC via spectroscopic analyses.
- In vitro cytotoxicity assays on normal and cancer cell lines (WI-38, Hep-G2, MCF-7).
- Antibacterial activity testing against VRSA clinical isolates (MIC, time-kill kinetics, membrane disruption).
- Evaluation of Ag-Se NC effects on VRSA biofilm development and eradication.
- Assessment of Ag-Se NC combined with vancomycin.
Main Results:
- Successfully synthesized Ag-Se NC with SPR peaks, high crystallinity, and ~35 nm spherical morphology.
- Ag-Se NC exhibited selective cytotoxicity, with low toxicity to normal cells (IC50 = 203.4 µg/mL) and potent inhibition of Hep-G2 (IC50 = 90.97 µg/mL) and MCF-7 (IC50 = 38.18 µg/mL) cells.
- Ag-Se NC showed significant antibacterial activity against 11 VRSA isolates (mean MIC = 203.64 µg/mL), rapid bactericidal kinetics, and membrane disruption.
- Ag-Se NC effectively inhibited VRSA biofilm formation (34.68-72.89%) and partially eradicated established biofilms (16.81-42.59%).
- Synergistic or additive interactions were observed when Ag-Se NC was combined with vancomycin against certain VRSA isolates.
Conclusions:
- Green-synthesized Ag-Se NC is a promising nanoplatform with combined anticancer and antibacterial properties.
- Ag-Se NC demonstrates efficacy against both planktonic and biofilm forms of VRSA.
- The nanocomposite shows potential for antimicrobial potentiation when used with existing antibiotics.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...


